Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 17 of 17 for “"Dry Powder Inhaler (DPI)"”.

  1. DEVELOPMENT AND OPTIMIZATION OF A LOW VOLUME AIR-JET DRY POWDER INHALER (DPI) PLATFORM FOR THE DELIVERY OF HIGH DOSE AEROSOLIZED POWDER TO INFANTS

    … project was to develop an infant air-jet dry powder inhaler (DPI) platform for high-efficiency nose-to-lung (N2L) aerosol administration to infants through optimization of individual system components followed by expansion of the system to higher doses and different formulations using a …

    vcu Repository record for DEVELOPMENT AND OPTIMIZATION OF A LOW VOLUME AIR-JET DRY POWDER INHALER (DPI) PLATFORM FOR THE DELIVERY OF HIGH DOSE AEROSOLIZED POWDER TO INFANTS (opens in a new tab)

  2. Surface properties of lactose carriers and their effect on drug delivery of dry powder inhaler

    Dry powder inhaler (DPI) is generally formulated by mixing micronized drug particles with larger carrier particles. The performance of DPI is affected by the carrier surface roughness. Scanning probe microscopy (SPM) is increasingly employed to assess surface roughness. In this study, topographical …

    nus Repository record for Surface properties of lactose carriers and their effect on drug delivery of dry powder inhaler (opens in a new tab) Download file for Surface properties of lactose carriers and their effect on drug delivery of dry powder inhaler (opens in a new tab)

  3. A STUDY ON SURFACE ROUGHNESS OF LACTOSE CARRIER PARTICLES

    … of micronized drug particles in carrier-based dry powder inhaler (DPI) formulations. This research work attempted to address several important aspects in the development of improved DPI formulations by surface roughening of lactose carrier particles. In the first part of the work, reliable …

    nus Repository record for A STUDY ON SURFACE ROUGHNESS OF LACTOSE CARRIER PARTICLES (opens in a new tab) Download file for A STUDY ON SURFACE ROUGHNESS OF LACTOSE CARRIER PARTICLES (opens in a new tab)

  4. Formulation development and physicochemical characterisation of liposomal antibiotic dry powders for inhaled treatment of chronic respiratory infections

    … to develop an inhalable liposomal apramycin dry powder formulation to achieve high local drug concentrations in the lungs while minimising systemic toxicity. An organic solvent-free (OSF) method was optimised for liposome manufacture, providing a reproducible and scalable process that avoids …

    qu-belfast Repository record for Formulation development and physicochemical characterisation of liposomal antibiotic dry powders for inhaled treatment of chronic respiratory infections (opens in a new tab) Embargoed until 2027-12-31

  5. Carrier-free high-dose dry-powder inhaler formulation of non-steroidal anti-inflammatory drugs

    … activities of IBU. Typically with inhaled powders, a binary formulation of a drug with a carrier, such as lactose, significantly improves their performance; however, this strategy is not practical for the delivery of a large drug dose via a dry powder inhaler (DPI). Other inhalation devices …

    texas Repository record for Carrier-free high-dose dry-powder inhaler formulation of non-steroidal anti-inflammatory drugs (opens in a new tab)

  6. Particle Engineering

    … tract lacks efficiency despite the variety of inhalers and formulations available. In the case of dry powder inhaler (DPI) formulations, scientists attribute this lack of efficiency to the variety of properties of the powder particles and the devices. Matching these interdependent properties is …

    cau-kiel Repository record for Particle Engineering (opens in a new tab)

  7. Advanced Design and Development of Novel Microparticulate/Nanoparticulate Dry Powder Inhalers Targeting Underlying Mechanisms in Respiratory Diseases

    … dose and reduce the unwarranted adverse effects. Dry powder inhaler (DPI) is a targeted drug delivery dosage form commonly used to target the airways to treat respiratory diseases. There are two components to dry powder inhaler product – powdered drug formulation and inhaler device; a unified …

    arizona-thes Repository record for Advanced Design and Development of Novel Microparticulate/Nanoparticulate Dry Powder Inhalers Targeting Underlying Mechanisms in Respiratory Diseases (opens in a new tab)

  8. Investigation into the effects of high shear blending and storage on powders for inhalation

    Dry powder inhaler (DPI) formulations are usually comprised of a mixture of micronised active pharmaceutical ingredient (API) with aerodynamic diameter 1-5 m to allow deposition in the lower airways, and a coarse (~70 micron) excipient, typically \(\alpha\)-lactose monohydrate, used to aid the …

    birmingham Download PDF for Investigation into the effects of high shear blending and storage on powders for inhalation (opens in a new tab)

  9. Twin-screw extrusion for development of complex dosage forms

    … controlled-release implants and 2) dry powder inhaler (DPI) blends for pulmonary delivery. In the first project, twin-screw extrusion was combined with single-screw extrusion to coextrude implants containing the contraceptive hormone etonogestrel and the nonbiodegradable polymer …

    texas Repository record for Twin-screw extrusion for development of complex dosage forms (opens in a new tab)

  10. Expanding the Performance and Functionality of Air-Jet Dry Powder Inhalers Across Multiple Applications

    … the performance and functionality of air-jet dry powder inhaler (DPI) applications through the development of a next-generation, mesh-nebulizer-based, and scalable spray dryer for the production of pharmaceutical aerosols, along with new spray-dried formulation production methods, novel …

    vcu Repository record for Expanding the Performance and Functionality of Air-Jet Dry Powder Inhalers Across Multiple Applications (opens in a new tab)

  11. MULTI-COMPONENT MICROPARTICULATE/NANOPARTICULATE DRY POWDER INHALATION AEROSOLS FOR TARGETED PULMONARY DELIVERY

    … and characterize targeted multi-component dry powder aerosols of (non-destructive) mucolytic agent (mannitol), antimicrobial drug (tobramycin or azithromycin), and lung surfactant mimic phospholipids (DPPC:DPPG=4:1 in molar ratio). The targeted dry powder for inhalation formulation for deep …

    uky-thes Repository record for MULTI-COMPONENT MICROPARTICULATE/NANOPARTICULATE DRY POWDER INHALATION AEROSOLS FOR TARGETED PULMONARY DELIVERY (opens in a new tab)

  12. Influence of engineered particulate lactose on the performance of DPI formulations

    Development of dry powder inhaler (DPI) formulations for respiratory diseases, such as Tuberculosis (TB), is challenging. The major limitation of current marketed DPIs is low delivery efficiency. In addition, delivered dose variation is also a challenging problem in the development and design of …

    texas Repository record for Influence of engineered particulate lactose on the performance of DPI formulations (opens in a new tab)

  13. Aerosolized Surfactants: Formulation Development and Evaluation of Aerosol Drug Delivery to the Lungs of Infants

    … this research project was to develop surfactant dry powder formulations and devices for efficient delivery of aerosol formulations to infants using the excipient enhanced growth (EEG) approach. Use of novel formulations and inline delivery devices would allow for more efficient treatment of …

    vcu Repository record for Aerosolized Surfactants: Formulation Development and Evaluation of Aerosol Drug Delivery to the Lungs of Infants (opens in a new tab)

  14. Nanostructured Lipid Carriers (NLCs) for Cancer Therapy via Pulmonary Drug Delivery

    … TC-NLC suspension formulations; and a mono dose inhaler (i.e., dry powder inhaler (DPI)) for the spray-dried (SD) SD-TC-NLC powder formulations. The spray drying technique was performed using two different carriers, lactose monohydrate (LAC) and trehalose dihydrate (TRE), in order to assess their …

    liverpool-jm Download PDF for Nanostructured Lipid Carriers (NLCs) for Cancer Therapy via Pulmonary Drug Delivery (opens in a new tab) Embargoed until 2027-05-08

  15. Dry Powders Inhalers (DPI) obtidos a partir de nanocápsulas de núcleo lipídico contendo budesonida : caracterização, avaliação in vivo em modelo animal de asma e da toxicidade in vitro em cultura celular

    … na forma de pó seco para inalação (Dry powders inhalers – DPI), obtido por aspersão contendo budesonida encapsulada, visando o tratamento da asma aguda e crônica. Essa proposta foi baseada na obtenção de um sistema pulverulento nanoestruturado com tamanho reduzido e controlado, …

    brazil-ufrgs Repository record for Dry Powders Inhalers (DPI) obtidos a partir de nanocápsulas de núcleo lipídico contendo budesonida : caracterização, avaliação in vivo em modelo animal de asma e da toxicidade in vitro em cultura celular (opens in a new tab)

  16. Nebulizer-based Systems to Improve Pharmaceutical Aerosol Delivery to the Lungs

    … safety study. A second focus created a Heated Dryer System (HDS) from similar concepts as the LVMH but designed for unsteady flows such as direct oral breathing. System aerosol delivery efficiency of approximately 90% to the tracheal filter of a simulated adult subject was found for the HDS …

    vcu Repository record for Nebulizer-based Systems to Improve Pharmaceutical Aerosol Delivery to the Lungs (opens in a new tab)